KALA BIO, Inc.
KALA
$0.57
$0.011.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.08M | -19.65M | -26.98M | -35.84M | -37.23M |
| Total Depreciation and Amortization | 182.00K | 249.00K | 317.00K | 332.00K | 267.00K |
| Total Amortization of Deferred Charges | -359.00K | -186.00K | 0.00 | -474.00K | -268.00K |
| Total Other Non-Cash Items | -3.57M | -944.00K | 193.00K | 7.06M | 10.89M |
| Change in Net Operating Assets | -6.04M | -5.53M | -5.52M | -3.11M | 457.00K |
| Cash from Operations | -19.86M | -26.06M | -31.99M | -32.03M | -25.88M |
| Capital Expenditure | 1.00K | 1.00K | 1.00K | -68.00K | -159.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.00M | -7.02M | -16.00K | -16.00K | -16.00K |
| Cash from Investing | -7.00M | -7.02M | -15.00K | -84.00K | -175.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -19.95M | -22.48M | -22.51M | -7.62M | -7.60M |
| Issuance of Common Stock | 9.19M | 9.19M | 9.21M | 11.75M | 11.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -162.00K |
| Issuance of Preferred Stock | 5.90M | 5.90M | 1.80M | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -120.00K | -120.00K | -120.00K |
| Cash from Financing | -4.85M | -7.38M | -11.62M | 4.01M | 3.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.71M | -40.46M | -43.62M | -28.11M | -22.26M |